Steffany N. Nguyen

Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system

Nicholas Jakowenko, Steffany N. Nguyen, Melanie Ruegger et al. · Thrombosis Research · 2020 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Evaluation of the impact of body mass index on warfarin requirements in hospitalized patients

Katie B. Tellor, Steffany N. Nguyen, Amanda C. Bultas et al. · Therapeutic Advances in Cardiovascular Disease · 2018 · 20 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events

Steffany N. Nguyen, Melanie Ruegger, Eric Salazar et al. · Journal of Pharmacy Practice · 2021 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +17

Apixaban and Rivaroxaban Anti-Xa Level Monitoring Versus Standard Monitoring in Hospitalized Patients With Acute Kidney Injury

William F. Towers, Steffany N. Nguyen, Melanie Ruegger et al. · Annals of Pharmacotherapy · 2021 · 12 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy

Jingshi Chen, Steffany N. Nguyen, Melanie Ruegger et al. · Journal of Thrombosis and Thrombolysis · 2022 · 11 citations

Medicine, Nephrology, Pharmacotherapy +17